Table 1 Baseline characteristics
| Â | Yoga group | Control group | p |
|---|---|---|---|
N | 15 | 9 | Â |
Current age in years, mean (SD) | 67 (9) | 68 (8) | 0.86 |
Female, N (%) | 9 (60%) | 5 (56%) | 0.83 |
Employed full- or part-time, N (%) | 5 (33%) | 3 (33%) | 1.00 |
Ex-smoker, N (%) | 5 (33%) | 3 (33%) | 1.00 |
Age of asthma diagnosis, median (IQR) | 11 (3, 48) | 40 (22, 45) | 0.20 |
Number of exacerbations in the last 12Â months, median (IQR) | 2 (1, 4) | 3 (2, 3) | 0.21 |
CCI, median (IQR) | 0 (0, 4) | 0 (0, 2) | 0.59 |
Current medication use | |||
 ICS/LABA, N (%) | 15 (100%) | 9 (100%) | N/A |
 ICS Beclomethasone equivalent dose, median (IQR) | 2000 (1000, 2000) | 2000 (1000, 2000) | 0.36 |
 Biological therapies, N (%) | 10 (67%) | 7 (78%) | 0.56 |
 LAMA, N (%) | 8 (53%) | 5 (56%) | 0.92 |
 LTRA, N (%) | 0 (0%) | 1 (11%) | 0.19 |
 Maintenance oral corticosteroid, N (%) | 5 (33%) | 2 (22%) | 0.56 |